DD236927A5 - Verfahren zur herstellung von 2-amino-3-ethyoxy-carbonylamino-6-(p-fluor-benzylamino)-pyridin-gluconat - Google Patents

Verfahren zur herstellung von 2-amino-3-ethyoxy-carbonylamino-6-(p-fluor-benzylamino)-pyridin-gluconat Download PDF

Info

Publication number
DD236927A5
DD236927A5 DD85275890A DD27589085A DD236927A5 DD 236927 A5 DD236927 A5 DD 236927A5 DD 85275890 A DD85275890 A DD 85275890A DD 27589085 A DD27589085 A DD 27589085A DD 236927 A5 DD236927 A5 DD 236927A5
Authority
DD
German Democratic Republic
Prior art keywords
amino
pyridine
ethoxycarbonylamino
benzylamino
fluoro
Prior art date
Application number
DD85275890A
Other languages
German (de)
English (en)
Inventor
Helmut Hettche
Peter Emig
Juergen Engel
Original Assignee
������@������������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@������������k�� filed Critical ������@������������k��
Publication of DD236927A5 publication Critical patent/DD236927A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/10Polyhydroxy carboxylic acids
    • C07C59/105Polyhydroxy carboxylic acids having five or more carbon atoms, e.g. aldonic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD85275890A 1984-05-05 1985-05-02 Verfahren zur herstellung von 2-amino-3-ethyoxy-carbonylamino-6-(p-fluor-benzylamino)-pyridin-gluconat DD236927A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843416609 DE3416609A1 (de) 1984-05-05 1984-05-05 2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)- pyridin-gluconat und pharmazeutische zubereitungen, die diese substanz enthalten

Publications (1)

Publication Number Publication Date
DD236927A5 true DD236927A5 (de) 1986-06-25

Family

ID=6235001

Family Applications (1)

Application Number Title Priority Date Filing Date
DD85275890A DD236927A5 (de) 1984-05-05 1985-05-02 Verfahren zur herstellung von 2-amino-3-ethyoxy-carbonylamino-6-(p-fluor-benzylamino)-pyridin-gluconat

Country Status (25)

Country Link
US (1) US4673666A (ja)
EP (1) EP0160865B1 (ja)
JP (1) JPS60239469A (ja)
KR (1) KR850008678A (ja)
AT (1) ATE33638T1 (ja)
AU (1) AU4194385A (ja)
BG (1) BG44537A3 (ja)
CA (1) CA1263398A (ja)
CS (1) CS248743B2 (ja)
DD (1) DD236927A5 (ja)
DE (2) DE3416609A1 (ja)
DK (1) DK157016C (ja)
ES (1) ES8603423A1 (ja)
FI (1) FI80443C (ja)
GR (1) GR851065B (ja)
HU (1) HU193753B (ja)
IE (1) IE57766B1 (ja)
IL (1) IL75086A (ja)
MC (1) MC1651A1 (ja)
NO (1) NO851772L (ja)
PL (1) PL253202A1 (ja)
PT (1) PT80386B (ja)
SU (1) SU1398772A3 (ja)
YU (1) YU71785A (ja)
ZA (1) ZA853351B (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117432A (en) * 1995-04-20 2000-09-12 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
US6689370B1 (en) 1995-04-20 2004-02-10 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
FR2733151B1 (fr) * 1995-04-20 1997-05-23 Seppic Sa Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines
US6821995B1 (en) 1999-12-01 2004-11-23 Duke University Method of treating batten disease
DE10327674A1 (de) * 2003-06-20 2005-01-05 Awd.Pharma Gmbh & Co. Kg Injizierbare Darreichungsform von Flupirtin
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
EP2350009B1 (en) * 2008-06-09 2016-03-16 TEVA GmbH Sulfonate salts of flupirtine
US8183267B2 (en) 2008-06-09 2012-05-22 Awd. Pharma Gmbh & Co. Kg Carboxylic acid salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine
DE102010030053A1 (de) 2010-06-14 2011-12-15 Awd.Pharma Gmbh & Co.Kg Injizierbare Darreichungsform von Flupirtin
WO2012004391A1 (en) 2010-07-09 2012-01-12 K.H.S. Pharma Holding Gmbh Process for the preparation of flupirtine maleate
CN102850265B (zh) * 2011-06-29 2015-11-25 陈小花 一种氟吡汀偶联物及其制备方法和用途
CN102351786A (zh) * 2011-11-01 2012-02-15 东南大学 一种氟吡汀丙二酸盐及其制备方法
CN103910674B (zh) * 2013-12-19 2015-12-02 天津红日药业股份有限公司 用于马来酸氟吡汀分析中的参比化合物
CN104974087A (zh) * 2015-01-30 2015-10-14 吉林修正药业新药开发有限公司 一种氟吡汀二聚体的合成方法
DE102017007385A1 (de) 2017-08-02 2019-02-07 Christoph Hoock Maleatfreie feste Arzneimittelformen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3133519A1 (de) * 1980-09-13 1982-06-09 Degussa Ag, 6000 Frankfurt "2-amino-3-carbethoxyamino-6-(p-fluor-benzylamino)-pyridin-maleat"
US4481205A (en) * 1980-09-13 1984-11-06 Degussa Aktiengesellschaft 2-Amino-3-carbethoxyamino-6-(p-fluoro-benzylamino)-pyridine-maleate

Also Published As

Publication number Publication date
DK157016B (da) 1989-10-30
IL75086A0 (en) 1985-09-29
KR850008678A (ko) 1985-12-21
CS248743B2 (en) 1987-02-12
ATE33638T1 (de) 1988-05-15
AU4194385A (en) 1985-11-07
YU71785A (en) 1988-02-29
ES542817A0 (es) 1985-12-16
EP0160865A3 (en) 1986-03-12
EP0160865B1 (de) 1988-04-20
PL253202A1 (en) 1986-07-15
IE851117L (en) 1985-11-05
JPS60239469A (ja) 1985-11-28
IL75086A (en) 1988-03-31
FI851752A0 (fi) 1985-05-03
HU193753B (en) 1987-11-30
ES8603423A1 (es) 1985-12-16
DK157016C (da) 1990-03-26
EP0160865A2 (de) 1985-11-13
PT80386A (de) 1985-06-01
IE57766B1 (en) 1993-03-24
DK198785A (da) 1985-11-06
CA1263398A (en) 1989-11-28
DK198785D0 (da) 1985-05-02
DE3416609A1 (de) 1985-11-07
HUT37758A (en) 1986-02-28
JPH0144185B2 (ja) 1989-09-26
GR851065B (ja) 1985-11-25
FI80443C (fi) 1990-06-11
SU1398772A3 (ru) 1988-05-23
BG44537A3 (en) 1988-12-15
FI80443B (fi) 1990-02-28
ZA853351B (en) 1985-12-24
MC1651A1 (fr) 1986-04-07
DE3562242D1 (en) 1988-05-26
PT80386B (de) 1987-04-16
NO851772L (no) 1985-11-06
US4673666A (en) 1987-06-16
FI851752L (fi) 1985-11-06

Similar Documents

Publication Publication Date Title
DD236927A5 (de) Verfahren zur herstellung von 2-amino-3-ethyoxy-carbonylamino-6-(p-fluor-benzylamino)-pyridin-gluconat
DE2655883A1 (de) Quarternaere ammoniumverbindungen und verfahren zu ihrer herstellung
AT397462B (de) Wässerige piroxicamlösungen
EP0806955B1 (de) Enrofloxacin-injektions- oder infusionslösungen
CH626085A5 (ja)
DE60131416T2 (de) Chirale fluochinolon-argininsalzformen
DE2641388C3 (de) 3',4'-Didesoxykanamycin B-N-methansulfonsäuren und deren Alkalimetallsalze sowie diese Verbindungen enthaltende pharmazeutische Präparate
DD218349A5 (de) Verfahren zur herstellung von 2-tert.-butylamino-3-chlorpropiophenonmaleat
DE2718730A1 (de) Cephalosporin-antibiotika
DE2632118C3 (de) Apovincaminolester und Verfahren zu deren Herstellung und Arzneimittel
EP0046506A1 (de) Vincamin-saccharinat und dieses enthaltende Arzneimittel
DE2231067A1 (de) Phenoxathiinderivate mit antiviraler wirkung, verfahren zu ihrer herstellung sowie pharmazeutische praeparate mit einem gehalt an phenoxathiinderivaten
DE2557033C2 (de) Acylderivate des 1,2-5,6-Dianhydro-dulcits, Verfahren zu deren Herstellung und diese Verbindungen enthaltende anticarcinogene Mittel
DE3509741A1 (de) Orale dosierungsform von etoposid
DD242405A5 (de) Verfahren zur herstellung einer neuen kristallinen form eines benzothlazindioxid-salzes
DE3843059A1 (de) Waessrige formulierungen, die ein piperidinylcyclopentylheptensaeure-derivat enthalten
DE2835987A1 (de) 3-amino-17a-aza-d-homo-5 alpha -androstanderivate und quaternaere salze davon sowie verfahren zu ihrer herstellung
EP0061654B1 (de) Vincamin-cyclamat, Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
DE2627706A1 (de) Sulfonamid/potentiatorloesungen
DE2235745C3 (de) 2-Amino-2',6'-propionoxylidid. Verfahren zu dessen Herstellung und dieses enthaltende Arzneimittel
DE1593975C3 (de) N-Chloracetyl-2- eckige Klammer auf (2'-methyl-3'-cMoranilino) carbonyl eckige Klammer zu-anilinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel. Ausscheidung aus: 1620385
DE2241076B2 (de) Tetracyclinkomplex und dessen Salze, Verfahren zu dessen Herstellung und diesen Komplex enthaltende pharmazeutische Zusammensetzungen
DE2549863C3 (de) Pyridoxyliden-p-amino-benzoesäurederivate, deren Herstellung und Verwendung
DE2629133C2 (de) 5"-Amino-3',5"-didesoxyribostamycin, Verfahren zu dessen Herstellung sowie antimikrobielle Zubereitungen
DE1795125C (de) Chinolinderivate, ein Verfahren zu ihrer Herstellung und Arzneimittel